D

Dis-Chem Pharmacies Ltd
JSE:DCP

Watchlist Manager
Dis-Chem Pharmacies Ltd
JSE:DCP
Watchlist
Price: 3 716 Zac -0.16% Market Closed
Market Cap: 31.9B Zac
Have any thoughts about
Dis-Chem Pharmacies Ltd?
Write Note

Net Margin
Dis-Chem Pharmacies Ltd

2.7%
Current
3%
Average
1.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.7%
=
Net Income
984.5m
/
Revenue
36.3B

Net Margin Across Competitors

Country ZA
Market Cap 31.9B Zac
Net Margin
3%
Country ZA
Market Cap 98.2B Zac
Net Margin
6%
Country BR
Market Cap 44.6B BRL
Net Margin
3%
Country US
Market Cap 7.5B USD
Net Margin
-6%
Country JP
Market Cap 845.2B JPY
Net Margin
5%
Country SA
Market Cap 16.8B SAR
Net Margin
9%
Country CN
Market Cap 27.3B CNY
Net Margin
6%
Country MX
Market Cap 70.6B MXN
Net Margin
4%
Country JP
Market Cap 547.7B JPY
Net Margin
3%
Country NL
Market Cap 2.9B EUR
Net Margin
-1%
Country JP
Market Cap 457.5B JPY
Net Margin
3%
No Stocks Found

Dis-Chem Pharmacies Ltd
Glance View

Market Cap
31.9B Zac
Industry
Retail

Dis-Chem Pharmacies Ltd. is a prominent South African retail pharmacy chain that has carved out a significant niche in the healthcare market since its inception in 1978. Founded by the visionary couple, Ivan and Lynette Bronfeld, Dis-Chem has grown from a single store in Mondeor to a network of over 200 pharmacies nationwide, offering a comprehensive range of pharmaceutical products, health and beauty items, and wellness services. The company's commitment to customer service, affordability, and community engagement has established it as a trusted brand among South African consumers, creating a loyal clientele that continues to drive revenue growth. For investors, Dis-Chem represents a promising opportunity in the evolving healthcare landscape. The company has consistently demonstrated robust financial performance, with revenue growth propelled by its expansion strategy and an increasing focus on e-commerce. With a well-diversified product offering that includes private label goods and prescription medications, Dis-Chem is well-positioned to capitalize on the growing demand for health services in South Africa. Furthermore, the company’s strategic focus on operational efficiency and cost management enhances its profitability, making it a compelling choice for investors seeking exposure to the retail pharmacy sector in a dynamic economic environment.

DCP Intrinsic Value
Not Available
D

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.7%
=
Net Income
984.5m
/
Revenue
36.3B
What is the Net Margin of Dis-Chem Pharmacies Ltd?

Based on Dis-Chem Pharmacies Ltd's most recent financial statements, the company has Net Margin of 2.7%.